425366-61-6 Usage
Description
Benzenemethanol, a-(aminomethyl)-4-chloro-, hydrochloride, (aS)is a chemical compound with the molecular formula C8H10ClNO. It is a hydrochloride salt form of the pharmaceutical intermediate known as aS-O-AminomethyltrasaM (ATS) hydrochloride, which is used in the synthesis of drugs like Dextroamphetamine sulfate. It is a chlorinated derivative of benzyl alcohol and is commonly used in the pharmaceutical industry for the production of psychoactive drugs and stimulants.
Uses
Used in Pharmaceutical Industry:
Benzenemethanol, a-(aminomethyl)-4-chloro-, hydrochloride, (aS)is used as a pharmaceutical intermediate for the synthesis of drugs like Dextroamphetamine sulfate. It is used as a reactant in the manufacture of various pharmaceutical compounds due to its ability to be easily modified and incorporated into complex drug molecules.
Used in Production of Psychoactive Drugs and Stimulants:
Benzenemethanol, a-(aminomethyl)-4-chloro-, hydrochloride, (aS)is used as a key component in the production of psychoactive drugs and stimulants. Its unique chemical structure allows it to interact with neurotransmitters in the brain, leading to increased alertness and focus.
Check Digit Verification of cas no
The CAS Registry Mumber 425366-61-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,2,5,3,6 and 6 respectively; the second part has 2 digits, 6 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 425366-61:
(8*4)+(7*2)+(6*5)+(5*3)+(4*6)+(3*6)+(2*6)+(1*1)=146
146 % 10 = 6
So 425366-61-6 is a valid CAS Registry Number.
425366-61-6Relevant articles and documents
Indole, indazole and indoline derivatives as CETP inhibitors
-
Page/Page column 27-28, (2010/02/15)
The present invention relates to compounds of formula (I): wherein —X—Y—, R1 to R11 and n are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prevention of diseases which are mediated by CETP inhibitors.